U.S., May 21 -- ClinicalTrials.gov registry received information related to the study (NCT07599904) titled 'REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)' on April 14.
Brief Summary: Post-Market Registry
Study Start Date: May, 2026
Study Type: OBSERVATIONAL
Condition:
Acute Ischemic Stroke
Intervention:
PROCEDURE: Device: Mechanical Thrombectomy
Index stroke procedure and follow-up visits up to 90 days post index procedure
Recruitment Status: NOT_YET_RECRUITING
Sponsor: Medtronic Neurovascular Clinical Affairs
Published by HT Digital Content Services with permission from Health Daily Digest....